Safety and Immunogenicity of VLA2001 Adults Aged ≥56 Years

NCT04956224 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2 Virus Infection

Interventions

BIOLOGICAL: VLA2001

Sponsor

Valneva Austria GmbH